SCHEMBL27737504

SCHEMBL27737504

O=COCCc1cnc2cnccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 2/20 0.35
▸ PDGFRB P09619 1/20 0.33
▸ PDGFRA P16234 1/20 0.33
▸ AKT1 P31749 1/20 0.32
▸ HDAC3 O15379 1/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ HDAC1 Q13547 1/20 0.32
▸ HDAC7 Q8WUI4 1/20 0.32
▸ HDAC2 Q92769 1/20 0.32
▸ HDAC10 Q969S8 1/20 0.32
▸ HDAC11 Q96DB2 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ HDAC9 Q9UKV0 1/20 0.32
▸ HDAC5 Q9UQL6 1/20 0.32
▸ TRPM5 Q9NZQ8 1/20 0.32
▸ HPGDS O60760 1/20 0.32
▸ TNF P01375 1/20 0.31
▸ KDM4C Q9H3R0 2/20 0.30
▸ FAAH O00519 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27490996 0.82 HDAC3 (0.46) PDGFRBPDGFRAHDAC3HDAC4HDAC1
SCHEMBL28042302 0.79 ESR2 (0.44) PDGFRBPDGFRAHDAC3HDAC4HDAC1
SCHEMBL28234144 0.75 PDGFRB (0.36) PDGFRBPDGFRA
SCHEMBL24447290 0.75 KDM4C (0.41) PDGFRBPDGFRAHPGDSKDM4C
SCHEMBL28382640 0.75 PIN1 (0.32) —
SCHEMBL272740 0.74 HDAC3 (0.44) PDGFRBPDGFRAHDAC3HDAC4HDAC1
SCHEMBL28295601 0.74 ACP1 (0.37) CYP2A6
SCHEMBL27653691 0.73 HDAC3 (0.43) PDGFRBPDGFRAHDAC3HDAC4HDAC1
SCHEMBL28058329 0.73 — —
SCHEMBL27798384 0.72 DAO (0.50) HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105473568-A 1, 7-naphthyridine derivatives HOFFMANN LA ROCHE 2016-04-06 — — CN disclosed
CN-101426373-A Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORP (US) 2009-05-06 — — CN disclosed
Send feedback